NR2C2 and prostate carcinoma: Taken together, they concluded that radiation-induced TR4 expression affects the radiosensitivity of prostate cancer through the QKI/circZEB1/miR-141-3p/ZEB1 axis, making prostate cancer radioresistant, and targeting TR4 therapy may be a solution [55].